database,exposure,outcomeCategory,Disease,denomPatid,denomIndexExp,timeWindow,numer,prevPct
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,12 months,1,0.6060606061
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,24 months,1,0.6060606061
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,36 months,1,0.6060606061
MPCD,DMARD,Cancer,Hematologic Cancer,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Cancer,Solid Cancer,145,165,12 months,7,4.2424242424
MPCD,DMARD,Cancer,Solid Cancer,145,165,24 months,13,7.8787878788
MPCD,DMARD,Cancer,Solid Cancer,145,165,36 months,13,7.8787878788
MPCD,DMARD,Cancer,Solid Cancer,145,165,AS cohort entry to exposure,6,3.6363636364
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,12 months,3,1.8181818182
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,24 months,3,1.8181818182
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,36 months,4,2.4242424242
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,145,165,AS cohort entry to exposure,2,1.2121212121
MPCD,DMARD,Infection,Hospitalized infection,145,165,12 months,6,3.6363636364
MPCD,DMARD,Infection,Hospitalized infection,145,165,24 months,11,6.6666666667
MPCD,DMARD,Infection,Hospitalized infection,145,165,36 months,14,8.4848484848
MPCD,DMARD,Infection,Hospitalized infection,145,165,AS cohort entry to exposure,7,4.2424242424
MPCD,DMARD,Infection,Opportunistic infection,145,165,12 months,5,3.0303030303
MPCD,DMARD,Infection,Opportunistic infection,145,165,24 months,9,5.4545454545
MPCD,DMARD,Infection,Opportunistic infection,145,165,36 months,13,7.8787878788
MPCD,DMARD,Infection,Opportunistic infection,145,165,AS cohort entry to exposure,3,1.8181818182
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,12 months,19,11.515151515
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,24 months,21,12.727272727
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,36 months,21,12.727272727
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,145,165,AS cohort entry to exposure,14,8.4848484848
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,12 months,11,6.6666666667
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,24 months,13,7.8787878788
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,36 months,13,7.8787878788
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,145,165,AS cohort entry to exposure,7,4.2424242424
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,12 months,1,0.6060606061
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,24 months,1,0.6060606061
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,36 months,1,0.6060606061
MPCD,DMARD,Kidney disease,IgA nephropathy,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Kidney disease,Nephrotic syndrome,145,165,12 months,1,0.6060606061
MPCD,DMARD,Kidney disease,Nephrotic syndrome,145,165,24 months,1,0.6060606061
MPCD,DMARD,Kidney disease,Nephrotic syndrome,145,165,36 months,1,0.6060606061
MPCD,DMARD,Kidney disease,Nephrotic syndrome,145,165,AS cohort entry to exposure,0,0
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,12 months,2,1.2121212121
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,24 months,3,1.8181818182
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,36 months,4,2.4242424242
MPCD,DMARD,Lung disease,Restrictive lung disease ,145,165,AS cohort entry to exposure,2,1.2121212121
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,12 months,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,24 months,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,36 months,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,12 months,2,1.2121212121
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,24 months,4,2.4242424242
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,36 months,6,3.6363636364
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,145,165,AS cohort entry to exposure,1,0.6060606061
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,12 months,7,4.2424242424
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,24 months,11,6.6666666667
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,36 months,14,8.4848484848
MPCD,DMARD,PsO/PsA,Psoriasis,145,165,AS cohort entry to exposure,6,3.6363636364
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,12 months,26,15.757575758
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,24 months,30,18.181818182
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,36 months,31,18.787878788
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,145,165,AS cohort entry to exposure,21,12.727272727
MPCD,DMARD,Uveitis,Uveitis,145,165,12 months,35,21.212121212
MPCD,DMARD,Uveitis,Uveitis,145,165,24 months,40,24.242424242
MPCD,DMARD,Uveitis,Uveitis,145,165,36 months,42,25.454545455
MPCD,DMARD,Uveitis,Uveitis,145,165,AS cohort entry to exposure,28,16.96969697
MPCD,NSAID,Cancer,Hematologic Cancer,265,355,12 months,1,0.2816901408
MPCD,NSAID,Cancer,Hematologic Cancer,265,355,24 months,1,0.2816901408
MPCD,NSAID,Cancer,Hematologic Cancer,265,355,36 months,1,0.2816901408
MPCD,NSAID,Cancer,Hematologic Cancer,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Cancer,Solid Cancer,265,355,12 months,28,7.8873239437
MPCD,NSAID,Cancer,Solid Cancer,265,355,24 months,35,9.8591549296
MPCD,NSAID,Cancer,Solid Cancer,265,355,36 months,36,10.14084507
MPCD,NSAID,Cancer,Solid Cancer,265,355,AS cohort entry to exposure,28,7.8873239437
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,12 months,2,0.5633802817
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,24 months,5,1.4084507042
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,36 months,5,1.4084507042
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,265,355,AS cohort entry to exposure,3,0.8450704225
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,12 months,7,1.9718309859
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,24 months,8,2.2535211268
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,36 months,9,2.5352112676
MPCD,NSAID,Cardiac disease,Conduction Block,265,355,AS cohort entry to exposure,2,0.5633802817
MPCD,NSAID,Cardiac disease,Myocardial infarction,265,355,12 months,1,0.2816901408
MPCD,NSAID,Cardiac disease,Myocardial infarction,265,355,24 months,3,0.8450704225
MPCD,NSAID,Cardiac disease,Myocardial infarction,265,355,36 months,3,0.8450704225
MPCD,NSAID,Cardiac disease,Myocardial infarction,265,355,AS cohort entry to exposure,0,0
MPCD,NSAID,Infection,Hospitalized infection,265,355,12 months,7,1.9718309859
MPCD,NSAID,Infection,Hospitalized infection,265,355,24 months,13,3.661971831
MPCD,NSAID,Infection,Hospitalized infection,265,355,36 months,14,3.9436619718
MPCD,NSAID,Infection,Hospitalized infection,265,355,AS cohort entry to exposure,11,3.0985915493
MPCD,NSAID,Infection,Opportunistic infection,265,355,12 months,5,1.4084507042
MPCD,NSAID,Infection,Opportunistic infection,265,355,24 months,6,1.6901408451
MPCD,NSAID,Infection,Opportunistic infection,265,355,36 months,7,1.9718309859
MPCD,NSAID,Infection,Opportunistic infection,265,355,AS cohort entry to exposure,7,1.9718309859
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,12 months,20,5.6338028169
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,24 months,23,6.4788732394
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,36 months,24,6.7605633803
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,265,355,AS cohort entry to exposure,18,5.0704225352
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,12 months,11,3.0985915493
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,24 months,13,3.661971831
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,36 months,13,3.661971831
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,265,355,AS cohort entry to exposure,15,4.2253521127
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,12 months,1,0.2816901408
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,24 months,3,0.8450704225
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,36 months,3,0.8450704225
MPCD,NSAID,Kidney disease,IgA nephropathy,265,355,AS cohort entry to exposure,1,0.2816901408
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,12 months,9,2.5352112676
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,24 months,14,3.9436619718
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,36 months,16,4.5070422535
MPCD,NSAID,Lung disease,Restrictive lung disease ,265,355,AS cohort entry to exposure,10,2.8169014085
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,12 months,3,0.8450704225
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,24 months,4,1.1267605634
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,36 months,4,1.1267605634
MPCD,NSAID,Neurological Disease,Spinal Cord compression,265,355,AS cohort entry to exposure,3,0.8450704225
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,12 months,9,2.5352112676
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,24 months,10,2.8169014085
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,36 months,11,3.0985915493
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,265,355,AS cohort entry to exposure,7,1.9718309859
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,12 months,15,4.2253521127
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,24 months,17,4.7887323944
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,36 months,19,5.3521126761
MPCD,NSAID,PsO/PsA,Psoriasis,265,355,AS cohort entry to exposure,18,5.0704225352
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,12 months,16,4.5070422535
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,24 months,20,5.6338028169
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,36 months,22,6.1971830986
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,265,355,AS cohort entry to exposure,14,3.9436619718
MPCD,NSAID,Uveitis,Uveitis,265,355,12 months,65,18.309859155
MPCD,NSAID,Uveitis,Uveitis,265,355,24 months,72,20.281690141
MPCD,NSAID,Uveitis,Uveitis,265,355,36 months,73,20.563380282
MPCD,NSAID,Uveitis,Uveitis,265,355,AS cohort entry to exposure,57,16.056338028
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,12 months,12,2.34375
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,24 months,17,3.3203125
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,36 months,18,3.515625
MPCD,No exposure,Cancer,Hematologic Cancer,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Cancer,Solid Cancer,512,512,12 months,82,16.015625
MPCD,No exposure,Cancer,Solid Cancer,512,512,24 months,114,22.265625
MPCD,No exposure,Cancer,Solid Cancer,512,512,36 months,127,24.8046875
MPCD,No exposure,Cancer,Solid Cancer,512,512,AS cohort entry to exposure,14,2.734375
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,12 months,39,7.6171875
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,24 months,50,9.765625
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,36 months,57,11.1328125
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,512,512,AS cohort entry to exposure,4,0.78125
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,12 months,16,3.125
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,24 months,21,4.1015625
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,36 months,25,4.8828125
MPCD,No exposure,Cardiac disease,Conduction Block,512,512,AS cohort entry to exposure,4,0.78125
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,12 months,12,2.34375
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,24 months,21,4.1015625
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,36 months,22,4.296875
MPCD,No exposure,Cardiac disease,Myocardial infarction,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Infection,Hospitalized infection,512,512,12 months,138,26.953125
MPCD,No exposure,Infection,Hospitalized infection,512,512,24 months,173,33.7890625
MPCD,No exposure,Infection,Hospitalized infection,512,512,36 months,183,35.7421875
MPCD,No exposure,Infection,Hospitalized infection,512,512,AS cohort entry to exposure,64,12.5
MPCD,No exposure,Infection,Opportunistic infection,512,512,12 months,16,3.125
MPCD,No exposure,Infection,Opportunistic infection,512,512,24 months,19,3.7109375
MPCD,No exposure,Infection,Opportunistic infection,512,512,36 months,23,4.4921875
MPCD,No exposure,Infection,Opportunistic infection,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,12 months,68,13.28125
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,24 months,77,15.0390625
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,36 months,83,16.2109375
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,512,512,AS cohort entry to exposure,19,3.7109375
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,12 months,37,7.2265625
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,24 months,43,8.3984375
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,36 months,44,8.59375
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,512,512,AS cohort entry to exposure,9,1.7578125
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,12 months,1,0.1953125
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,24 months,2,0.390625
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,36 months,3,0.5859375
MPCD,No exposure,Kidney disease,Amyloidosis,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,12 months,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,24 months,1,0.1953125
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,36 months,3,0.5859375
MPCD,No exposure,Kidney disease,IgA nephropathy,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,12 months,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,24 months,1,0.1953125
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,36 months,1,0.1953125
MPCD,No exposure,Kidney disease,Nephrotic syndrome,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,12 months,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,24 months,1,0.1953125
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,36 months,1,0.1953125
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,512,512,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Interstitial lung disease,512,512,12 months,2,0.390625
MPCD,No exposure,Lung disease,Interstitial lung disease,512,512,24 months,4,0.78125
MPCD,No exposure,Lung disease,Interstitial lung disease,512,512,36 months,4,0.78125
MPCD,No exposure,Lung disease,Interstitial lung disease,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,12 months,31,6.0546875
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,24 months,49,9.5703125
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,36 months,54,10.546875
MPCD,No exposure,Lung disease,Restrictive lung disease ,512,512,AS cohort entry to exposure,10,1.953125
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,12 months,4,0.78125
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,24 months,5,0.9765625
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,36 months,5,0.9765625
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,512,512,AS cohort entry to exposure,3,0.5859375
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,12 months,3,0.5859375
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,24 months,4,0.78125
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,36 months,6,1.171875
MPCD,No exposure,Neurological Disease,Spinal Cord compression,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,12 months,11,2.1484375
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,24 months,14,2.734375
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,36 months,15,2.9296875
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,512,512,AS cohort entry to exposure,1,0.1953125
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,12 months,14,2.734375
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,24 months,25,4.8828125
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,36 months,26,5.078125
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,512,512,AS cohort entry to exposure,2,0.390625
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,12 months,34,6.640625
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,24 months,49,9.5703125
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,36 months,52,10.15625
MPCD,No exposure,PsO/PsA,Psoriasis,512,512,AS cohort entry to exposure,8,1.5625
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,12 months,47,9.1796875
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,24 months,56,10.9375
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,36 months,64,12.5
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,512,512,AS cohort entry to exposure,15,2.9296875
MPCD,No exposure,Uveitis,Uveitis,512,512,12 months,97,18.9453125
MPCD,No exposure,Uveitis,Uveitis,512,512,24 months,118,23.046875
MPCD,No exposure,Uveitis,Uveitis,512,512,36 months,129,25.1953125
MPCD,No exposure,Uveitis,Uveitis,512,512,AS cohort entry to exposure,25,4.8828125
MPCD,TNF,Cancer,Hematologic Cancer,575,670,12 months,4,0.5970149254
MPCD,TNF,Cancer,Hematologic Cancer,575,670,24 months,5,0.7462686567
MPCD,TNF,Cancer,Hematologic Cancer,575,670,36 months,5,0.7462686567
MPCD,TNF,Cancer,Hematologic Cancer,575,670,AS cohort entry to exposure,4,0.5970149254
MPCD,TNF,Cancer,Solid Cancer,575,670,12 months,33,4.9253731343
MPCD,TNF,Cancer,Solid Cancer,575,670,24 months,41,6.1194029851
MPCD,TNF,Cancer,Solid Cancer,575,670,36 months,44,6.5671641791
MPCD,TNF,Cancer,Solid Cancer,575,670,AS cohort entry to exposure,19,2.8358208955
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,12 months,22,3.2835820896
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,24 months,27,4.0298507463
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,36 months,28,4.1791044776
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,575,670,AS cohort entry to exposure,18,2.6865671642
MPCD,TNF,Cardiac disease,Conduction Block,575,670,12 months,3,0.447761194
MPCD,TNF,Cardiac disease,Conduction Block,575,670,24 months,3,0.447761194
MPCD,TNF,Cardiac disease,Conduction Block,575,670,36 months,3,0.447761194
MPCD,TNF,Cardiac disease,Conduction Block,575,670,AS cohort entry to exposure,1,0.1492537313
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,12 months,4,0.5970149254
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,24 months,7,1.0447761194
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,36 months,7,1.0447761194
MPCD,TNF,Cardiac disease,Myocardial infarction,575,670,AS cohort entry to exposure,3,0.447761194
MPCD,TNF,Infection,Hospitalized infection,575,670,12 months,13,1.9402985075
MPCD,TNF,Infection,Hospitalized infection,575,670,24 months,22,3.2835820896
MPCD,TNF,Infection,Hospitalized infection,575,670,36 months,24,3.5820895522
MPCD,TNF,Infection,Hospitalized infection,575,670,AS cohort entry to exposure,14,2.0895522388
MPCD,TNF,Infection,Opportunistic infection,575,670,12 months,17,2.5373134328
MPCD,TNF,Infection,Opportunistic infection,575,670,24 months,22,3.2835820896
MPCD,TNF,Infection,Opportunistic infection,575,670,36 months,23,3.4328358209
MPCD,TNF,Infection,Opportunistic infection,575,670,AS cohort entry to exposure,10,1.4925373134
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,12 months,74,11.044776119
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,24 months,82,12.23880597
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,36 months,85,12.686567164
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,575,670,AS cohort entry to exposure,65,9.7014925373
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,12 months,39,5.8208955224
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,24 months,45,6.7164179104
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,36 months,47,7.0149253731
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,575,670,AS cohort entry to exposure,27,4.0298507463
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,12 months,4,0.5970149254
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,24 months,4,0.5970149254
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,36 months,4,0.5970149254
MPCD,TNF,Kidney disease,IgA nephropathy,575,670,AS cohort entry to exposure,1,0.1492537313
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,12 months,2,0.2985074627
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,24 months,2,0.2985074627
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,36 months,2,0.2985074627
MPCD,TNF,Kidney disease,Nephrotic syndrome,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,12 months,9,1.3432835821
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,24 months,15,2.2388059701
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,36 months,17,2.5373134328
MPCD,TNF,Lung disease,Restrictive lung disease ,575,670,AS cohort entry to exposure,10,1.4925373134
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,12 months,2,0.2985074627
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,24 months,2,0.2985074627
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,36 months,2,0.2985074627
MPCD,TNF,Neurological Disease,Spinal Cord compression,575,670,AS cohort entry to exposure,0,0
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,12 months,9,1.3432835821
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,24 months,10,1.4925373134
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,36 months,10,1.4925373134
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,575,670,AS cohort entry to exposure,6,0.8955223881
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,12 months,11,1.6417910448
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,24 months,14,2.0895522388
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,36 months,14,2.0895522388
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,575,670,AS cohort entry to exposure,6,0.8955223881
MPCD,TNF,PsO/PsA,Psoriasis,575,670,12 months,55,8.2089552239
MPCD,TNF,PsO/PsA,Psoriasis,575,670,24 months,67,10
MPCD,TNF,PsO/PsA,Psoriasis,575,670,36 months,72,10.746268657
MPCD,TNF,PsO/PsA,Psoriasis,575,670,AS cohort entry to exposure,37,5.5223880597
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,12 months,83,12.388059701
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,24 months,98,14.626865672
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,36 months,103,15.373134328
MPCD,TNF,PsO/PsA,Psoriatic arthritis,575,670,AS cohort entry to exposure,70,10.447761194
MPCD,TNF,Uveitis,Uveitis,575,670,12 months,108,16.119402985
MPCD,TNF,Uveitis,Uveitis,575,670,24 months,121,18.059701493
MPCD,TNF,Uveitis,Uveitis,575,670,36 months,126,18.805970149
MPCD,TNF,Uveitis,Uveitis,575,670,AS cohort entry to exposure,90,13.432835821
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,12 months,16,2.0592020592
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,24 months,22,2.8314028314
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,36 months,23,2.9601029601
Marketscan,DMARD,Cancer,Hematologic Cancer,710,777,AS cohort entry to exposure,12,1.5444015444
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,12 months,10,1.287001287
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,24 months,22,2.8314028314
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,36 months,27,3.4749034749
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,710,777,AS cohort entry to exposure,6,0.7722007722
Marketscan,DMARD,Cancer,Solid Cancer,710,777,12 months,85,10.93951094
Marketscan,DMARD,Cancer,Solid Cancer,710,777,24 months,103,13.256113256
Marketscan,DMARD,Cancer,Solid Cancer,710,777,36 months,115,14.800514801
Marketscan,DMARD,Cancer,Solid Cancer,710,777,AS cohort entry to exposure,59,7.5933075933
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,12 months,18,2.3166023166
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,24 months,28,3.6036036036
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,36 months,34,4.3758043758
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,710,777,AS cohort entry to exposure,13,1.6731016731
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,12 months,23,2.9601029601
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,24 months,30,3.861003861
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,36 months,32,4.1184041184
Marketscan,DMARD,Cardiac disease,Conduction Block,710,777,AS cohort entry to exposure,13,1.6731016731
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,12 months,3,0.3861003861
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,24 months,6,0.7722007722
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,36 months,8,1.0296010296
Marketscan,DMARD,Cardiac disease,Myocardial infarction,710,777,AS cohort entry to exposure,5,0.6435006435
Marketscan,DMARD,Infection,Hospitalized infection,710,777,12 months,99,12.741312741
Marketscan,DMARD,Infection,Hospitalized infection,710,777,24 months,142,18.275418275
Marketscan,DMARD,Infection,Hospitalized infection,710,777,36 months,151,19.433719434
Marketscan,DMARD,Infection,Hospitalized infection,710,777,AS cohort entry to exposure,88,11.325611326
Marketscan,DMARD,Infection,Opportunistic infection,710,777,12 months,31,3.9897039897
Marketscan,DMARD,Infection,Opportunistic infection,710,777,24 months,45,5.7915057915
Marketscan,DMARD,Infection,Opportunistic infection,710,777,36 months,49,6.3063063063
Marketscan,DMARD,Infection,Opportunistic infection,710,777,AS cohort entry to exposure,22,2.8314028314
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,12 months,79,10.167310167
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,24 months,88,11.325611326
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,36 months,92,11.84041184
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,710,777,AS cohort entry to exposure,69,8.8803088803
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,12 months,53,6.8211068211
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,24 months,63,8.1081081081
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,36 months,67,8.6229086229
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,710,777,AS cohort entry to exposure,28,3.6036036036
Marketscan,DMARD,Kidney disease,Amyloidosis,710,777,12 months,0,0
Marketscan,DMARD,Kidney disease,Amyloidosis,710,777,24 months,1,0.1287001287
Marketscan,DMARD,Kidney disease,Amyloidosis,710,777,36 months,1,0.1287001287
Marketscan,DMARD,Kidney disease,Amyloidosis,710,777,AS cohort entry to exposure,0,0
Marketscan,DMARD,Kidney disease,IgA nephropathy,710,777,12 months,1,0.1287001287
Marketscan,DMARD,Kidney disease,IgA nephropathy,710,777,24 months,1,0.1287001287
Marketscan,DMARD,Kidney disease,IgA nephropathy,710,777,36 months,1,0.1287001287
Marketscan,DMARD,Kidney disease,IgA nephropathy,710,777,AS cohort entry to exposure,1,0.1287001287
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,12 months,1,0.1287001287
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,24 months,2,0.2574002574
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,36 months,3,0.3861003861
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,710,777,AS cohort entry to exposure,0,0
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,12 months,3,0.3861003861
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,24 months,4,0.5148005148
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,36 months,4,0.5148005148
Marketscan,DMARD,Lung disease,Interstitial lung disease,710,777,AS cohort entry to exposure,2,0.2574002574
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,12 months,15,1.9305019305
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,24 months,22,2.8314028314
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,36 months,33,4.2471042471
Marketscan,DMARD,Lung disease,Restrictive lung disease ,710,777,AS cohort entry to exposure,18,2.3166023166
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,710,777,12 months,3,0.3861003861
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,710,777,24 months,3,0.3861003861
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,710,777,36 months,3,0.3861003861
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,710,777,AS cohort entry to exposure,0,0
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,12 months,4,0.5148005148
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,24 months,9,1.1583011583
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,36 months,10,1.287001287
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,710,777,AS cohort entry to exposure,2,0.2574002574
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,12 months,5,0.6435006435
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,24 months,6,0.7722007722
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,36 months,8,1.0296010296
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,710,777,AS cohort entry to exposure,3,0.3861003861
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,12 months,6,0.7722007722
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,24 months,12,1.5444015444
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,36 months,15,1.9305019305
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,710,777,AS cohort entry to exposure,7,0.9009009009
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,12 months,73,9.3951093951
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,24 months,87,11.196911197
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,36 months,100,12.87001287
Marketscan,DMARD,PsO/PsA,Psoriasis,710,777,AS cohort entry to exposure,49,6.3063063063
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,12 months,131,16.85971686
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,24 months,153,19.691119691
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,36 months,157,20.205920206
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,710,777,AS cohort entry to exposure,87,11.196911197
Marketscan,DMARD,Uveitis,Uveitis,710,777,12 months,139,17.889317889
Marketscan,DMARD,Uveitis,Uveitis,710,777,24 months,166,21.364221364
Marketscan,DMARD,Uveitis,Uveitis,710,777,36 months,175,22.522522523
Marketscan,DMARD,Uveitis,Uveitis,710,777,AS cohort entry to exposure,103,13.256113256
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,12 months,21,1.2117714945
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,24 months,27,1.5579919215
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,36 months,29,1.6733987305
Marketscan,NSAID,Cancer,Hematologic Cancer,1293,1733,AS cohort entry to exposure,26,1.500288517
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,12 months,43,2.4812463935
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,24 months,64,3.6930178881
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,36 months,72,4.1546451241
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,1293,1733,AS cohort entry to exposure,46,2.654356607
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,12 months,177,10.213502597
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,24 months,219,12.637045586
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,36 months,231,13.32948644
Marketscan,NSAID,Cancer,Solid Cancer,1293,1733,AS cohort entry to exposure,152,8.7709174841
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,12 months,36,2.077322562
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,24 months,46,2.654356607
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,36 months,49,2.8274668205
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1293,1733,AS cohort entry to exposure,44,2.538949798
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,12 months,47,2.7120600115
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,24 months,69,3.9815349106
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,36 months,77,4.4431621466
Marketscan,NSAID,Cardiac disease,Conduction Block,1293,1733,AS cohort entry to exposure,39,2.2504327755
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,12 months,19,1.0963646855
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,24 months,24,1.384881708
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,36 months,32,1.846508944
Marketscan,NSAID,Cardiac disease,Myocardial infarction,1293,1733,AS cohort entry to exposure,18,1.038661281
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,12 months,238,13.733410271
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,24 months,305,17.599538373
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,36 months,335,19.330640508
Marketscan,NSAID,Infection,Hospitalized infection,1293,1733,AS cohort entry to exposure,257,14.829774957
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,12 months,41,2.3658395845
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,24 months,50,2.885170225
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,36 months,58,3.3467974611
Marketscan,NSAID,Infection,Opportunistic infection,1293,1733,AS cohort entry to exposure,35,2.0196191575
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,12 months,89,5.1356030006
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,24 months,102,5.8857472591
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,36 months,108,6.2319676861
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,1293,1733,AS cohort entry to exposure,81,4.6739757646
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,12 months,57,3.2890940565
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,24 months,63,3.6353144836
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,36 months,68,3.9238315061
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,1293,1733,AS cohort entry to exposure,45,2.5966532025
Marketscan,NSAID,Kidney disease,Amyloidosis,1293,1733,12 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,Amyloidosis,1293,1733,24 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,Amyloidosis,1293,1733,36 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,Amyloidosis,1293,1733,AS cohort entry to exposure,0,0
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,12 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,24 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,36 months,2,0.115406809
Marketscan,NSAID,Kidney disease,IgA nephropathy,1293,1733,AS cohort entry to exposure,1,0.0577034045
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,12 months,1,0.0577034045
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,24 months,2,0.115406809
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,36 months,3,0.1731102135
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,1293,1733,AS cohort entry to exposure,0,0
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,12 months,2,0.115406809
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,24 months,3,0.1731102135
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,36 months,3,0.1731102135
Marketscan,NSAID,Lung disease,Interstitial lung disease,1293,1733,AS cohort entry to exposure,2,0.115406809
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,12 months,36,2.077322562
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,24 months,44,2.538949798
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,36 months,51,2.9428736295
Marketscan,NSAID,Lung disease,Restrictive lung disease ,1293,1733,AS cohort entry to exposure,38,2.192729371
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,12 months,25,1.4425851125
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,24 months,35,2.0196191575
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,36 months,36,2.077322562
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,1293,1733,AS cohort entry to exposure,16,0.923254472
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,12 months,18,1.038661281
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,24 months,21,1.2117714945
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,36 months,24,1.384881708
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,1293,1733,AS cohort entry to exposure,9,0.5193306405
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,12 months,24,1.384881708
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,24 months,31,1.7888055395
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,36 months,36,2.077322562
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1293,1733,AS cohort entry to exposure,26,1.500288517
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,12 months,94,5.4241200231
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,24 months,119,6.8667051356
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,36 months,138,7.9630698211
Marketscan,NSAID,PsO/PsA,Psoriasis,1293,1733,AS cohort entry to exposure,81,4.6739757646
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,12 months,111,6.4050778996
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,24 months,133,7.6745527986
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,36 months,143,8.2515868436
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,1293,1733,AS cohort entry to exposure,104,6.0011540681
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,12 months,329,18.984420081
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,24 months,387,22.331217542
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,36 months,410,23.658395845
Marketscan,NSAID,Uveitis,Uveitis,1293,1733,AS cohort entry to exposure,269,15.522215811
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,12 months,44,2.5897586816
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,24 months,49,2.8840494408
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,36 months,55,3.237198352
Marketscan,No exposure,Cancer,Hematologic Cancer,1699,1699,AS cohort entry to exposure,11,0.6474396704
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,12 months,42,2.4720423779
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,24 months,77,4.5320776928
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,36 months,94,5.5326662743
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,12 months,247,14.537963508
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,24 months,295,17.363154797
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,36 months,328,19.305473808
Marketscan,No exposure,Cancer,Solid Cancer,1699,1699,AS cohort entry to exposure,48,2.825191289
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,12 months,105,6.1801059447
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,24 months,130,7.651559741
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,36 months,143,8.4167157151
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1699,1699,AS cohort entry to exposure,17,1.0005885815
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,12 months,108,6.3566804002
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,24 months,139,8.1812831077
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,36 months,154,9.0641553855
Marketscan,No exposure,Cardiac disease,Conduction Block,1699,1699,AS cohort entry to exposure,40,2.3543260742
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,12 months,51,3.0017657446
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,24 months,62,3.6492054149
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,36 months,67,3.9434961742
Marketscan,No exposure,Cardiac disease,Myocardial infarction,1699,1699,AS cohort entry to exposure,21,1.2360211889
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,12 months,521,30.665097116
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,24 months,624,36.727486757
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,36 months,673,39.611536198
Marketscan,No exposure,Infection,Hospitalized infection,1699,1699,AS cohort entry to exposure,224,13.184226015
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,12 months,60,3.5314891112
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,24 months,81,4.7675103002
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,36 months,95,5.5915244261
Marketscan,No exposure,Infection,Opportunistic infection,1699,1699,AS cohort entry to exposure,3,0.1765744556
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,12 months,195,11.477339612
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,24 months,229,13.478516775
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,36 months,240,14.125956445
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,1699,1699,AS cohort entry to exposure,78,4.5909358446
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,12 months,166,9.7704532078
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,24 months,186,10.947616245
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,36 months,194,11.41848146
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1699,1699,AS cohort entry to exposure,41,2.413184226
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,12 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,24 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,36 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Amyloidosis,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,12 months,9,0.5297233667
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,24 months,10,0.5885815185
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,36 months,10,0.5885815185
Marketscan,No exposure,Kidney disease,IgA nephropathy,1699,1699,AS cohort entry to exposure,2,0.1177163037
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,12 months,1,0.0588581519
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,24 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,36 months,2,0.1177163037
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Apical Pulmonary fibrosis,1699,1699,12 months,2,0.1177163037
Marketscan,No exposure,Lung disease,Apical Pulmonary fibrosis,1699,1699,24 months,2,0.1177163037
Marketscan,No exposure,Lung disease,Apical Pulmonary fibrosis,1699,1699,36 months,2,0.1177163037
Marketscan,No exposure,Lung disease,Apical Pulmonary fibrosis,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,12 months,9,0.5297233667
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,24 months,10,0.5885815185
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,36 months,11,0.6474396704
Marketscan,No exposure,Lung disease,Interstitial lung disease,1699,1699,AS cohort entry to exposure,4,0.2354326074
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,12 months,105,6.1801059447
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,24 months,131,7.7104178929
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,36 months,150,8.8287227781
Marketscan,No exposure,Lung disease,Restrictive lung disease ,1699,1699,AS cohort entry to exposure,29,1.7068864038
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,12 months,4,0.2354326074
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,24 months,5,0.2942907593
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,36 months,5,0.2942907593
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,12 months,20,1.1771630371
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,24 months,26,1.5303119482
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,36 months,28,1.6480282519
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,1699,1699,AS cohort entry to exposure,6,0.3531489111
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,12 months,14,0.824014126
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,24 months,23,1.3537374926
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,36 months,26,1.5303119482
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1699,1699,AS cohort entry to exposure,1,0.0588581519
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,12 months,17,1.0005885815
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,24 months,28,1.6480282519
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,36 months,33,1.9423190112
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1699,1699,AS cohort entry to exposure,0,0
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,12 months,125,7.3572689818
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,24 months,153,9.0052972337
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,36 months,173,10.182460271
Marketscan,No exposure,PsO/PsA,Psoriasis,1699,1699,AS cohort entry to exposure,28,1.6480282519
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,12 months,147,8.6521483225
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,24 months,179,10.535609182
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,36 months,197,11.595055915
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,1699,1699,AS cohort entry to exposure,43,2.5309005297
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,12 months,445,26.191877575
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,24 months,514,30.253090053
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,36 months,541,31.842260153
Marketscan,No exposure,Uveitis,Uveitis,1699,1699,AS cohort entry to exposure,95,5.5915244261
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,12 months,8,0.2316825948
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,24 months,16,0.4633651897
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,36 months,16,0.4633651897
Marketscan,TNF,Cancer,Hematologic Cancer,2864,3453,AS cohort entry to exposure,5,0.1448016218
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,12 months,30,0.8688097307
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,24 months,59,1.708659137
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,36 months,72,2.0851433536
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,2864,3453,AS cohort entry to exposure,26,0.7529684332
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,12 months,103,2.9829134086
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,24 months,145,4.1992470316
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,36 months,157,4.5467709238
Marketscan,TNF,Cancer,Solid Cancer,2864,3453,AS cohort entry to exposure,80,2.3168259485
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,12 months,47,1.3611352447
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,24 months,59,1.708659137
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,36 months,70,2.0272227049
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2864,3453,AS cohort entry to exposure,37,1.0715320012
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,12 months,41,1.1873732986
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,24 months,60,1.7376194613
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,36 months,71,2.0561830292
Marketscan,TNF,Cardiac disease,Conduction Block,2864,3453,AS cohort entry to exposure,30,0.8688097307
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,12 months,11,0.3185635679
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,24 months,20,0.5792064871
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,36 months,21,0.6081668115
Marketscan,TNF,Cardiac disease,Myocardial infarction,2864,3453,AS cohort entry to exposure,16,0.4633651897
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,12 months,204,5.9079061685
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,24 months,293,8.4853750362
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,36 months,332,9.6148276861
Marketscan,TNF,Infection,Hospitalized infection,2864,3453,AS cohort entry to exposure,194,5.618302925
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,12 months,68,1.9693020562
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,24 months,91,2.6353895164
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,36 months,101,2.9249927599
Marketscan,TNF,Infection,Opportunistic infection,2864,3453,AS cohort entry to exposure,59,1.708659137
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,12 months,320,9.2673037938
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,24 months,362,10.483637417
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,36 months,373,10.802200985
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,2864,3453,AS cohort entry to exposure,258,7.4717636838
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,12 months,209,6.0527077903
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,24 months,237,6.8635968723
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,36 months,254,7.3559223863
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,2864,3453,AS cohort entry to exposure,150,4.3440486533
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,12 months,2,0.0579206487
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,24 months,4,0.1158412974
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,36 months,4,0.1158412974
Marketscan,TNF,Kidney disease,Amyloidosis,2864,3453,AS cohort entry to exposure,0,0
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,12 months,7,0.2027222705
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,24 months,9,0.2606429192
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,36 months,10,0.2896032436
Marketscan,TNF,Kidney disease,IgA nephropathy,2864,3453,AS cohort entry to exposure,5,0.1448016218
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,12 months,4,0.1158412974
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,24 months,6,0.1737619461
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,36 months,6,0.1737619461
Marketscan,TNF,Kidney disease,Nephrotic syndrome,2864,3453,AS cohort entry to exposure,3,0.0868809731
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,2864,3453,12 months,1,0.0289603244
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,2864,3453,24 months,1,0.0289603244
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,2864,3453,36 months,1,0.0289603244
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,2864,3453,AS cohort entry to exposure,0,0
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,12 months,6,0.1737619461
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,24 months,6,0.1737619461
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,36 months,6,0.1737619461
Marketscan,TNF,Lung disease,Interstitial lung disease,2864,3453,AS cohort entry to exposure,4,0.1158412974
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,12 months,50,1.4480162178
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,24 months,72,2.0851433536
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,36 months,82,2.3747465972
Marketscan,TNF,Lung disease,Restrictive lung disease ,2864,3453,AS cohort entry to exposure,34,0.9846510281
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,12 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,24 months,1,0.0289603244
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,36 months,2,0.0579206487
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,2864,3453,AS cohort entry to exposure,0,0
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,12 months,9,0.2606429192
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,24 months,14,0.405444541
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,36 months,25,0.7240081089
Marketscan,TNF,Neurological Disease,Spinal Cord compression,2864,3453,AS cohort entry to exposure,3,0.0868809731
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,12 months,14,0.405444541
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,24 months,23,0.6660874602
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,36 months,24,0.6950477845
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,2864,3453,AS cohort entry to exposure,7,0.2027222705
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,12 months,26,0.7529684332
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,24 months,58,1.6796988126
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,36 months,67,1.9403417318
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2864,3453,AS cohort entry to exposure,22,0.6371271358
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,12 months,252,7.2980017376
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,24 months,322,9.3252244425
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,36 months,361,10.454677092
Marketscan,TNF,PsO/PsA,Psoriasis,2864,3453,AS cohort entry to exposure,179,5.1838980597
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,12 months,409,11.844772661
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,24 months,476,13.785114393
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,36 months,496,14.36432088
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,2864,3453,AS cohort entry to exposure,334,9.6727483348
Marketscan,TNF,Uveitis,Uveitis,2864,3453,12 months,448,12.974225311
Marketscan,TNF,Uveitis,Uveitis,2864,3453,24 months,517,14.972487692
Marketscan,TNF,Uveitis,Uveitis,2864,3453,36 months,553,16.015059369
Marketscan,TNF,Uveitis,Uveitis,2864,3453,AS cohort entry to exposure,375,10.860121633
Medicare,DMARD,Cancer,Hematologic Cancer,1432,1688,12 months,85,5.0355450237
Medicare,DMARD,Cancer,Hematologic Cancer,1432,1688,24 months,109,6.4573459716
Medicare,DMARD,Cancer,Hematologic Cancer,1432,1688,36 months,118,6.990521327
Medicare,DMARD,Cancer,Hematologic Cancer,1432,1688,AS cohort entry to exposure,72,4.2654028436
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1432,1688,12 months,67,3.9691943128
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1432,1688,24 months,118,6.990521327
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1432,1688,36 months,159,9.4194312796
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1432,1688,AS cohort entry to exposure,55,3.2582938389
Medicare,DMARD,Cancer,Solid Cancer,1432,1688,12 months,399,23.637440758
Medicare,DMARD,Cancer,Solid Cancer,1432,1688,24 months,515,30.509478673
Medicare,DMARD,Cancer,Solid Cancer,1432,1688,36 months,583,34.537914692
Medicare,DMARD,Cancer,Solid Cancer,1432,1688,AS cohort entry to exposure,340,20.142180095
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1432,1688,12 months,192,11.374407583
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1432,1688,24 months,288,17.061611374
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1432,1688,36 months,336,19.90521327
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1432,1688,AS cohort entry to exposure,161,9.5379146919
Medicare,DMARD,Cardiac disease,Conduction Block,1432,1688,12 months,155,9.182464455
Medicare,DMARD,Cardiac disease,Conduction Block,1432,1688,24 months,228,13.507109005
Medicare,DMARD,Cardiac disease,Conduction Block,1432,1688,36 months,280,16.587677725
Medicare,DMARD,Cardiac disease,Conduction Block,1432,1688,AS cohort entry to exposure,130,7.7014218009
Medicare,DMARD,Cardiac disease,Myocardial infarction,1432,1688,12 months,47,2.7843601896
Medicare,DMARD,Cardiac disease,Myocardial infarction,1432,1688,24 months,86,5.0947867299
Medicare,DMARD,Cardiac disease,Myocardial infarction,1432,1688,36 months,125,7.4052132701
Medicare,DMARD,Cardiac disease,Myocardial infarction,1432,1688,AS cohort entry to exposure,54,3.1990521327
Medicare,DMARD,Infection,Hospitalized infection,1432,1688,12 months,717,42.476303318
Medicare,DMARD,Infection,Hospitalized infection,1432,1688,24 months,1058,62.677725118
Medicare,DMARD,Infection,Hospitalized infection,1432,1688,36 months,1292,76.54028436
Medicare,DMARD,Infection,Hospitalized infection,1432,1688,AS cohort entry to exposure,825,48.874407583
Medicare,DMARD,Infection,Opportunistic infection,1432,1688,12 months,144,8.5308056872
Medicare,DMARD,Infection,Opportunistic infection,1432,1688,24 months,212,12.559241706
Medicare,DMARD,Infection,Opportunistic infection,1432,1688,36 months,251,14.869668246
Medicare,DMARD,Infection,Opportunistic infection,1432,1688,AS cohort entry to exposure,160,9.4786729858
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1432,1688,12 months,342,20.260663507
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1432,1688,24 months,371,21.978672986
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1432,1688,36 months,386,22.867298578
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1432,1688,AS cohort entry to exposure,320,18.957345972
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1432,1688,12 months,187,11.078199052
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1432,1688,24 months,222,13.151658768
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1432,1688,36 months,239,14.158767773
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1432,1688,AS cohort entry to exposure,199,11.789099526
Medicare,DMARD,Kidney disease,Amyloidosis,1432,1688,12 months,2,0.1184834123
Medicare,DMARD,Kidney disease,Amyloidosis,1432,1688,24 months,2,0.1184834123
Medicare,DMARD,Kidney disease,Amyloidosis,1432,1688,36 months,2,0.1184834123
Medicare,DMARD,Kidney disease,Amyloidosis,1432,1688,AS cohort entry to exposure,2,0.1184834123
Medicare,DMARD,Kidney disease,IgA nephropathy,1432,1688,12 months,10,0.5924170616
Medicare,DMARD,Kidney disease,IgA nephropathy,1432,1688,24 months,16,0.9478672986
Medicare,DMARD,Kidney disease,IgA nephropathy,1432,1688,36 months,20,1.1848341232
Medicare,DMARD,Kidney disease,IgA nephropathy,1432,1688,AS cohort entry to exposure,11,0.6516587678
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1432,1688,12 months,12,0.7109004739
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1432,1688,24 months,19,1.1255924171
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1432,1688,36 months,20,1.1848341232
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1432,1688,AS cohort entry to exposure,8,0.4739336493
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1432,1688,12 months,2,0.1184834123
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1432,1688,24 months,2,0.1184834123
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1432,1688,36 months,2,0.1184834123
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1432,1688,AS cohort entry to exposure,2,0.1184834123
Medicare,DMARD,Lung disease,Interstitial lung disease,1432,1688,12 months,57,3.3767772512
Medicare,DMARD,Lung disease,Interstitial lung disease,1432,1688,24 months,86,5.0947867299
Medicare,DMARD,Lung disease,Interstitial lung disease,1432,1688,36 months,100,5.9241706161
Medicare,DMARD,Lung disease,Interstitial lung disease,1432,1688,AS cohort entry to exposure,60,3.5545023697
Medicare,DMARD,Lung disease,Restrictive lung disease ,1432,1688,12 months,176,10.426540284
Medicare,DMARD,Lung disease,Restrictive lung disease ,1432,1688,24 months,252,14.928909953
Medicare,DMARD,Lung disease,Restrictive lung disease ,1432,1688,36 months,311,18.424170616
Medicare,DMARD,Lung disease,Restrictive lung disease ,1432,1688,AS cohort entry to exposure,194,11.492890995
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1432,1688,12 months,1,0.0592417062
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1432,1688,24 months,1,0.0592417062
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1432,1688,36 months,3,0.1777251185
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1432,1688,AS cohort entry to exposure,7,0.4146919431
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1432,1688,12 months,21,1.2440758294
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1432,1688,24 months,32,1.8957345972
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1432,1688,36 months,34,2.0142180095
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1432,1688,AS cohort entry to exposure,30,1.7772511848
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1432,1688,12 months,31,1.836492891
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1432,1688,24 months,52,3.0805687204
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1432,1688,36 months,70,4.1469194313
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1432,1688,AS cohort entry to exposure,41,2.4289099526
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1432,1688,12 months,49,2.9028436019
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1432,1688,24 months,95,5.6279620853
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1432,1688,36 months,119,7.0497630332
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1432,1688,AS cohort entry to exposure,79,4.6800947867
Medicare,DMARD,PsO/PsA,Psoriasis,1432,1688,12 months,251,14.869668246
Medicare,DMARD,PsO/PsA,Psoriasis,1432,1688,24 months,331,19.609004739
Medicare,DMARD,PsO/PsA,Psoriasis,1432,1688,36 months,386,22.867298578
Medicare,DMARD,PsO/PsA,Psoriasis,1432,1688,AS cohort entry to exposure,251,14.869668246
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1432,1688,12 months,422,25
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1432,1688,24 months,477,28.258293839
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1432,1688,36 months,514,30.450236967
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1432,1688,AS cohort entry to exposure,394,23.341232227
Medicare,DMARD,Uveitis,Uveitis,1432,1688,12 months,259,15.343601896
Medicare,DMARD,Uveitis,Uveitis,1432,1688,24 months,319,18.898104265
Medicare,DMARD,Uveitis,Uveitis,1432,1688,36 months,361,21.386255924
Medicare,DMARD,Uveitis,Uveitis,1432,1688,AS cohort entry to exposure,292,17.298578199
Medicare,NSAID,Cancer,Hematologic Cancer,2755,4147,12 months,195,4.7021943574
Medicare,NSAID,Cancer,Hematologic Cancer,2755,4147,24 months,226,5.4497226911
Medicare,NSAID,Cancer,Hematologic Cancer,2755,4147,36 months,255,6.1490233904
Medicare,NSAID,Cancer,Hematologic Cancer,2755,4147,AS cohort entry to exposure,211,5.0880154328
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,2755,4147,12 months,239,5.7632023149
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,2755,4147,24 months,375,9.0426814565
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,2755,4147,36 months,482,11.622859899
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,2755,4147,AS cohort entry to exposure,236,5.6908608633
Medicare,NSAID,Cancer,Solid Cancer,2755,4147,12 months,1174,28.309621413
Medicare,NSAID,Cancer,Solid Cancer,2755,4147,24 months,1430,34.482758621
Medicare,NSAID,Cancer,Solid Cancer,2755,4147,36 months,1598,38.533879913
Medicare,NSAID,Cancer,Solid Cancer,2755,4147,AS cohort entry to exposure,1225,29.539426091
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2755,4147,12 months,489,11.791656619
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2755,4147,24 months,642,15.481070653
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2755,4147,36 months,755,18.205931999
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2755,4147,AS cohort entry to exposure,591,14.251265975
Medicare,NSAID,Cardiac disease,Conduction Block,2755,4147,12 months,422,10.176030866
Medicare,NSAID,Cardiac disease,Conduction Block,2755,4147,24 months,630,15.191704847
Medicare,NSAID,Cardiac disease,Conduction Block,2755,4147,36 months,768,18.519411623
Medicare,NSAID,Cardiac disease,Conduction Block,2755,4147,AS cohort entry to exposure,587,14.154810707
Medicare,NSAID,Cardiac disease,Myocardial infarction,2755,4147,12 months,105,2.5319508078
Medicare,NSAID,Cardiac disease,Myocardial infarction,2755,4147,24 months,199,4.7986496262
Medicare,NSAID,Cardiac disease,Myocardial infarction,2755,4147,36 months,257,6.1972510248
Medicare,NSAID,Cardiac disease,Myocardial infarction,2755,4147,AS cohort entry to exposure,168,4.0511212925
Medicare,NSAID,Infection,Hospitalized infection,2755,4147,12 months,1711,41.258741259
Medicare,NSAID,Infection,Hospitalized infection,2755,4147,24 months,2421,58.379551483
Medicare,NSAID,Infection,Hospitalized infection,2755,4147,36 months,2868,69.158427779
Medicare,NSAID,Infection,Hospitalized infection,2755,4147,AS cohort entry to exposure,2468,59.512900892
Medicare,NSAID,Infection,Opportunistic infection,2755,4147,12 months,251,6.0525681215
Medicare,NSAID,Infection,Opportunistic infection,2755,4147,24 months,410,9.8866650591
Medicare,NSAID,Infection,Opportunistic infection,2755,4147,36 months,532,12.82855076
Medicare,NSAID,Infection,Opportunistic infection,2755,4147,AS cohort entry to exposure,383,9.2355919942
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,2755,4147,12 months,404,9.7419821558
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,2755,4147,24 months,470,11.333494092
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,2755,4147,36 months,499,12.032794791
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,2755,4147,AS cohort entry to exposure,492,11.863998071
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2755,4147,12 months,215,5.1844707017
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2755,4147,24 months,278,6.7036411864
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2755,4147,36 months,327,7.88521823
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2755,4147,AS cohort entry to exposure,324,7.8128767784
Medicare,NSAID,Kidney disease,Amyloidosis,2755,4147,12 months,7,0.1687967205
Medicare,NSAID,Kidney disease,Amyloidosis,2755,4147,24 months,7,0.1687967205
Medicare,NSAID,Kidney disease,Amyloidosis,2755,4147,36 months,9,0.217024355
Medicare,NSAID,Kidney disease,Amyloidosis,2755,4147,AS cohort entry to exposure,10,0.2411381722
Medicare,NSAID,Kidney disease,IgA nephropathy,2755,4147,12 months,15,0.3617072583
Medicare,NSAID,Kidney disease,IgA nephropathy,2755,4147,24 months,20,0.4822763443
Medicare,NSAID,Kidney disease,IgA nephropathy,2755,4147,36 months,28,0.6751868821
Medicare,NSAID,Kidney disease,IgA nephropathy,2755,4147,AS cohort entry to exposure,42,1.0127803231
Medicare,NSAID,Kidney disease,Nephrotic syndrome,2755,4147,12 months,15,0.3617072583
Medicare,NSAID,Kidney disease,Nephrotic syndrome,2755,4147,24 months,19,0.4581625271
Medicare,NSAID,Kidney disease,Nephrotic syndrome,2755,4147,36 months,19,0.4581625271
Medicare,NSAID,Kidney disease,Nephrotic syndrome,2755,4147,AS cohort entry to exposure,17,0.4099348927
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,2755,4147,12 months,3,0.0723414517
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,2755,4147,24 months,3,0.0723414517
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,2755,4147,36 months,3,0.0723414517
Medicare,NSAID,Lung disease,Apical Pulmonary fibrosis,2755,4147,AS cohort entry to exposure,3,0.0723414517
Medicare,NSAID,Lung disease,Interstitial lung disease,2755,4147,12 months,62,1.4950566675
Medicare,NSAID,Lung disease,Interstitial lung disease,2755,4147,24 months,87,2.0979020979
Medicare,NSAID,Lung disease,Interstitial lung disease,2755,4147,36 months,107,2.5801784422
Medicare,NSAID,Lung disease,Interstitial lung disease,2755,4147,AS cohort entry to exposure,99,2.3872679045
Medicare,NSAID,Lung disease,Restrictive lung disease ,2755,4147,12 months,334,8.0540149506
Medicare,NSAID,Lung disease,Restrictive lung disease ,2755,4147,24 months,525,12.659754039
Medicare,NSAID,Lung disease,Restrictive lung disease ,2755,4147,36 months,645,15.553412105
Medicare,NSAID,Lung disease,Restrictive lung disease ,2755,4147,AS cohort entry to exposure,506,12.201591512
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,2755,4147,12 months,10,0.2411381722
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,2755,4147,24 months,15,0.3617072583
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,2755,4147,36 months,16,0.3858210755
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,2755,4147,AS cohort entry to exposure,20,0.4822763443
Medicare,NSAID,Neurological Disease,Spinal Cord compression,2755,4147,12 months,60,1.446829033
Medicare,NSAID,Neurological Disease,Spinal Cord compression,2755,4147,24 months,82,1.9773330118
Medicare,NSAID,Neurological Disease,Spinal Cord compression,2755,4147,36 months,97,2.3390402701
Medicare,NSAID,Neurological Disease,Spinal Cord compression,2755,4147,AS cohort entry to exposure,95,2.2908126356
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2755,4147,12 months,141,3.4000482276
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2755,4147,24 months,211,5.0880154328
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2755,4147,36 months,238,5.7390884977
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2755,4147,AS cohort entry to exposure,194,4.6780805401
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2755,4147,12 months,146,3.5206173137
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2755,4147,24 months,229,5.5220641428
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2755,4147,36 months,289,6.9688931758
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2755,4147,AS cohort entry to exposure,280,6.7518688208
Medicare,NSAID,PsO/PsA,Psoriasis,2755,4147,12 months,378,9.1150229081
Medicare,NSAID,PsO/PsA,Psoriasis,2755,4147,24 months,504,12.153363878
Medicare,NSAID,PsO/PsA,Psoriasis,2755,4147,36 months,579,13.961900169
Medicare,NSAID,PsO/PsA,Psoriasis,2755,4147,AS cohort entry to exposure,513,12.370388232
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,2755,4147,12 months,345,8.31926694
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,2755,4147,24 months,414,9.9831203279
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,2755,4147,36 months,450,10.851217748
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,2755,4147,AS cohort entry to exposure,529,12.756209308
Medicare,NSAID,Uveitis,Uveitis,2755,4147,12 months,482,11.622859899
Medicare,NSAID,Uveitis,Uveitis,2755,4147,24 months,661,15.939233181
Medicare,NSAID,Uveitis,Uveitis,2755,4147,36 months,760,18.326501085
Medicare,NSAID,Uveitis,Uveitis,2755,4147,AS cohort entry to exposure,701,16.903785869
Medicare,No exposure,Cancer,Hematologic Cancer,2489,2489,12 months,260,10.445962234
Medicare,No exposure,Cancer,Hematologic Cancer,2489,2489,24 months,298,11.972679791
Medicare,No exposure,Cancer,Hematologic Cancer,2489,2489,36 months,329,13.218159904
Medicare,No exposure,Cancer,Hematologic Cancer,2489,2489,AS cohort entry to exposure,54,2.1695460024
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,2489,2489,12 months,336,13.499397348
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,2489,2489,24 months,510,20.490156689
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,2489,2489,36 months,589,23.664122137
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,2489,2489,AS cohort entry to exposure,7,0.2812374448
Medicare,No exposure,Cancer,Solid Cancer,2489,2489,12 months,1579,63.439132182
Medicare,No exposure,Cancer,Solid Cancer,2489,2489,24 months,1902,76.416231418
Medicare,No exposure,Cancer,Solid Cancer,2489,2489,36 months,2057,82.643631981
Medicare,No exposure,Cancer,Solid Cancer,2489,2489,AS cohort entry to exposure,194,7.7942948975
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2489,2489,12 months,805,32.342306147
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2489,2489,24 months,1021,41.020490157
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2489,2489,36 months,1125,45.19887505
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2489,2489,AS cohort entry to exposure,106,4.2587384492
Medicare,No exposure,Cardiac disease,Conduction Block,2489,2489,12 months,782,31.418240257
Medicare,No exposure,Cardiac disease,Conduction Block,2489,2489,24 months,1022,41.060666935
Medicare,No exposure,Cardiac disease,Conduction Block,2489,2489,36 months,1178,47.328244275
Medicare,No exposure,Cardiac disease,Conduction Block,2489,2489,AS cohort entry to exposure,150,6.0265166734
Medicare,No exposure,Cardiac disease,Myocardial infarction,2489,2489,12 months,333,13.378867015
Medicare,No exposure,Cardiac disease,Myocardial infarction,2489,2489,24 months,450,18.07955002
Medicare,No exposure,Cardiac disease,Myocardial infarction,2489,2489,36 months,529,21.253515468
Medicare,No exposure,Cardiac disease,Myocardial infarction,2489,2489,AS cohort entry to exposure,93,3.7364403375
Medicare,No exposure,Infection,Hospitalized infection,2489,2489,12 months,3257,130.85576537
Medicare,No exposure,Infection,Hospitalized infection,2489,2489,24 months,4032,161.99276818
Medicare,No exposure,Infection,Hospitalized infection,2489,2489,36 months,4437,178.2643632
Medicare,No exposure,Infection,Hospitalized infection,2489,2489,AS cohort entry to exposure,1031,41.422257935
Medicare,No exposure,Infection,Opportunistic infection,2489,2489,12 months,341,13.700281237
Medicare,No exposure,Infection,Opportunistic infection,2489,2489,24 months,480,19.284853355
Medicare,No exposure,Infection,Opportunistic infection,2489,2489,36 months,576,23.141824026
Medicare,No exposure,Infection,Opportunistic infection,2489,2489,AS cohort entry to exposure,33,1.3258336681
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,2489,2489,12 months,619,24.869425472
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,2489,2489,24 months,682,27.400562475
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,2489,2489,36 months,717,28.806749699
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,2489,2489,AS cohort entry to exposure,194,7.7942948975
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,2489,2489,12 months,336,13.499397348
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,2489,2489,24 months,414,16.633186018
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,2489,2489,36 months,465,18.682201687
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,2489,2489,AS cohort entry to exposure,61,2.4507834472
Medicare,No exposure,Kidney disease,Amyloidosis,2489,2489,12 months,12,0.4821213339
Medicare,No exposure,Kidney disease,Amyloidosis,2489,2489,24 months,13,0.5222981117
Medicare,No exposure,Kidney disease,Amyloidosis,2489,2489,36 months,15,0.6026516673
Medicare,No exposure,Kidney disease,Amyloidosis,2489,2489,AS cohort entry to exposure,1,0.0401767778
Medicare,No exposure,Kidney disease,IgA nephropathy,2489,2489,12 months,34,1.366010446
Medicare,No exposure,Kidney disease,IgA nephropathy,2489,2489,24 months,51,2.0490156689
Medicare,No exposure,Kidney disease,IgA nephropathy,2489,2489,36 months,62,2.490960225
Medicare,No exposure,Kidney disease,IgA nephropathy,2489,2489,AS cohort entry to exposure,4,0.1607071113
Medicare,No exposure,Kidney disease,Nephrotic syndrome,2489,2489,12 months,28,1.124949779
Medicare,No exposure,Kidney disease,Nephrotic syndrome,2489,2489,24 months,33,1.3258336681
Medicare,No exposure,Kidney disease,Nephrotic syndrome,2489,2489,36 months,37,1.4865407794
Medicare,No exposure,Kidney disease,Nephrotic syndrome,2489,2489,AS cohort entry to exposure,1,0.0401767778
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,2489,2489,12 months,2,0.0803535556
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,2489,2489,24 months,3,0.1205303335
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,2489,2489,36 months,3,0.1205303335
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,2489,2489,AS cohort entry to exposure,1,0.0401767778
Medicare,No exposure,Lung disease,Interstitial lung disease,2489,2489,12 months,98,3.9373242266
Medicare,No exposure,Lung disease,Interstitial lung disease,2489,2489,24 months,131,5.2631578947
Medicare,No exposure,Lung disease,Interstitial lung disease,2489,2489,36 months,147,5.9059863399
Medicare,No exposure,Lung disease,Interstitial lung disease,2489,2489,AS cohort entry to exposure,26,1.0445962234
Medicare,No exposure,Lung disease,Restrictive lung disease ,2489,2489,12 months,474,19.043792688
Medicare,No exposure,Lung disease,Restrictive lung disease ,2489,2489,24 months,667,26.797910808
Medicare,No exposure,Lung disease,Restrictive lung disease ,2489,2489,36 months,792,31.820008035
Medicare,No exposure,Lung disease,Restrictive lung disease ,2489,2489,AS cohort entry to exposure,55,2.2097227802
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,2489,2489,12 months,35,1.4061872238
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,2489,2489,24 months,42,1.6874246685
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,2489,2489,36 months,44,1.7677782242
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,2489,2489,AS cohort entry to exposure,9,0.3615910004
Medicare,No exposure,Neurological Disease,Spinal Cord compression,2489,2489,12 months,135,5.423865006
Medicare,No exposure,Neurological Disease,Spinal Cord compression,2489,2489,24 months,157,6.3077541181
Medicare,No exposure,Neurological Disease,Spinal Cord compression,2489,2489,36 months,167,6.7095218963
Medicare,No exposure,Neurological Disease,Spinal Cord compression,2489,2489,AS cohort entry to exposure,20,0.8035355564
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,2489,2489,12 months,64,2.5713137806
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,2489,2489,24 months,105,4.2185616714
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,2489,2489,36 months,137,5.5042185617
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,2489,2489,AS cohort entry to exposure,5,0.2008838891
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2489,2489,12 months,66,2.6516673363
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2489,2489,24 months,114,4.5801526718
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2489,2489,36 months,146,5.8658095621
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2489,2489,AS cohort entry to exposure,2,0.0803535556
Medicare,No exposure,PsO/PsA,Psoriasis,2489,2489,12 months,441,17.71795902
Medicare,No exposure,PsO/PsA,Psoriasis,2489,2489,24 months,572,22.981116914
Medicare,No exposure,PsO/PsA,Psoriasis,2489,2489,36 months,628,25.231016472
Medicare,No exposure,PsO/PsA,Psoriasis,2489,2489,AS cohort entry to exposure,68,2.7320208919
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,2489,2489,12 months,470,18.883085577
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,2489,2489,24 months,540,21.695460024
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,2489,2489,36 months,579,23.262354359
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,2489,2489,AS cohort entry to exposure,111,4.4596223383
Medicare,No exposure,Uveitis,Uveitis,2489,2489,12 months,432,17.356368019
Medicare,No exposure,Uveitis,Uveitis,2489,2489,24 months,550,22.097227802
Medicare,No exposure,Uveitis,Uveitis,2489,2489,36 months,620,24.90960225
Medicare,No exposure,Uveitis,Uveitis,2489,2489,AS cohort entry to exposure,57,2.2900763359
Medicare,TNF,Cancer,Hematologic Cancer,2660,3268,12 months,26,0.7955936353
Medicare,TNF,Cancer,Hematologic Cancer,2660,3268,24 months,44,1.3463892289
Medicare,TNF,Cancer,Hematologic Cancer,2660,3268,36 months,56,1.7135862913
Medicare,TNF,Cancer,Hematologic Cancer,2660,3268,AS cohort entry to exposure,28,0.8567931457
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,2660,3268,12 months,72,2.2031823745
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,2660,3268,24 months,116,3.5495716034
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,2660,3268,36 months,153,4.6817625459
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,2660,3268,AS cohort entry to exposure,69,2.1113831089
Medicare,TNF,Cancer,Solid Cancer,2660,3268,12 months,338,10.342717258
Medicare,TNF,Cancer,Solid Cancer,2660,3268,24 months,422,12.913096695
Medicare,TNF,Cancer,Solid Cancer,2660,3268,36 months,484,14.810281518
Medicare,TNF,Cancer,Solid Cancer,2660,3268,AS cohort entry to exposure,291,8.9045287638
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2660,3268,12 months,174,5.3243574051
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2660,3268,24 months,239,7.3133414933
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2660,3268,36 months,276,8.4455324357
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2660,3268,AS cohort entry to exposure,172,5.2631578947
Medicare,TNF,Cardiac disease,Conduction Block,2660,3268,12 months,145,4.4369645043
Medicare,TNF,Cardiac disease,Conduction Block,2660,3268,24 months,210,6.4259485924
Medicare,TNF,Cardiac disease,Conduction Block,2660,3268,36 months,262,8.0171358629
Medicare,TNF,Cardiac disease,Conduction Block,2660,3268,AS cohort entry to exposure,131,4.0085679315
Medicare,TNF,Cardiac disease,Myocardial infarction,2660,3268,12 months,29,0.8873929009
Medicare,TNF,Cardiac disease,Myocardial infarction,2660,3268,24 months,62,1.8971848225
Medicare,TNF,Cardiac disease,Myocardial infarction,2660,3268,36 months,87,2.6621787026
Medicare,TNF,Cardiac disease,Myocardial infarction,2660,3268,AS cohort entry to exposure,58,1.7747858017
Medicare,TNF,Infection,Hospitalized infection,2660,3268,12 months,542,16.585067319
Medicare,TNF,Infection,Hospitalized infection,2660,3268,24 months,925,28.304773562
Medicare,TNF,Infection,Hospitalized infection,2660,3268,36 months,1132,34.638922889
Medicare,TNF,Infection,Hospitalized infection,2660,3268,AS cohort entry to exposure,673,20.593635251
Medicare,TNF,Infection,Opportunistic infection,2660,3268,12 months,161,4.9265605875
Medicare,TNF,Infection,Opportunistic infection,2660,3268,24 months,240,7.3439412485
Medicare,TNF,Infection,Opportunistic infection,2660,3268,36 months,287,8.782129743
Medicare,TNF,Infection,Opportunistic infection,2660,3268,AS cohort entry to exposure,192,5.8751529988
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,2660,3268,12 months,497,15.208078335
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,2660,3268,24 months,538,16.462668299
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,2660,3268,36 months,554,16.952264382
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,2660,3268,AS cohort entry to exposure,459,14.045287638
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,2660,3268,12 months,229,7.0073439412
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,2660,3268,24 months,288,8.8127294982
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,2660,3268,36 months,314,9.6083231334
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,2660,3268,AS cohort entry to exposure,229,7.0073439412
Medicare,TNF,Kidney disease,Amyloidosis,2660,3268,12 months,6,0.1835985312
Medicare,TNF,Kidney disease,Amyloidosis,2660,3268,24 months,11,0.3365973072
Medicare,TNF,Kidney disease,Amyloidosis,2660,3268,36 months,11,0.3365973072
Medicare,TNF,Kidney disease,Amyloidosis,2660,3268,AS cohort entry to exposure,7,0.2141982864
Medicare,TNF,Kidney disease,IgA nephropathy,2660,3268,12 months,7,0.2141982864
Medicare,TNF,Kidney disease,IgA nephropathy,2660,3268,24 months,15,0.458996328
Medicare,TNF,Kidney disease,IgA nephropathy,2660,3268,36 months,22,0.6731946144
Medicare,TNF,Kidney disease,IgA nephropathy,2660,3268,AS cohort entry to exposure,17,0.5201958384
Medicare,TNF,Kidney disease,Nephrotic syndrome,2660,3268,12 months,12,0.3671970624
Medicare,TNF,Kidney disease,Nephrotic syndrome,2660,3268,24 months,22,0.6731946144
Medicare,TNF,Kidney disease,Nephrotic syndrome,2660,3268,36 months,25,0.76499388
Medicare,TNF,Kidney disease,Nephrotic syndrome,2660,3268,AS cohort entry to exposure,8,0.2447980416
Medicare,TNF,Lung disease,Interstitial lung disease,2660,3268,12 months,25,0.76499388
Medicare,TNF,Lung disease,Interstitial lung disease,2660,3268,24 months,42,1.2851897185
Medicare,TNF,Lung disease,Interstitial lung disease,2660,3268,36 months,56,1.7135862913
Medicare,TNF,Lung disease,Interstitial lung disease,2660,3268,AS cohort entry to exposure,36,1.1015911873
Medicare,TNF,Lung disease,Restrictive lung disease ,2660,3268,12 months,145,4.4369645043
Medicare,TNF,Lung disease,Restrictive lung disease ,2660,3268,24 months,246,7.5275397797
Medicare,TNF,Lung disease,Restrictive lung disease ,2660,3268,36 months,295,9.0269277846
Medicare,TNF,Lung disease,Restrictive lung disease ,2660,3268,AS cohort entry to exposure,184,5.6303549572
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,2660,3268,12 months,8,0.2447980416
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,2660,3268,24 months,13,0.3977968176
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,2660,3268,36 months,14,0.4283965728
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,2660,3268,AS cohort entry to exposure,3,0.0917992656
Medicare,TNF,Neurological Disease,Spinal Cord compression,2660,3268,12 months,15,0.458996328
Medicare,TNF,Neurological Disease,Spinal Cord compression,2660,3268,24 months,22,0.6731946144
Medicare,TNF,Neurological Disease,Spinal Cord compression,2660,3268,36 months,31,0.9485924113
Medicare,TNF,Neurological Disease,Spinal Cord compression,2660,3268,AS cohort entry to exposure,23,0.7037943696
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,2660,3268,12 months,51,1.5605875153
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,2660,3268,24 months,99,3.029375765
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,2660,3268,36 months,115,3.5189718482
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,2660,3268,AS cohort entry to exposure,64,1.9583843329
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2660,3268,12 months,73,2.2337821297
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2660,3268,24 months,133,4.0697674419
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2660,3268,36 months,172,5.2631578947
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2660,3268,AS cohort entry to exposure,113,3.4577723378
Medicare,TNF,PsO/PsA,Psoriasis,2660,3268,12 months,416,12.729498164
Medicare,TNF,PsO/PsA,Psoriasis,2660,3268,24 months,519,15.88127295
Medicare,TNF,PsO/PsA,Psoriasis,2660,3268,36 months,568,17.380660955
Medicare,TNF,PsO/PsA,Psoriasis,2660,3268,AS cohort entry to exposure,392,11.995104039
Medicare,TNF,PsO/PsA,Psoriatic arthritis,2660,3268,12 months,624,19.094247246
Medicare,TNF,PsO/PsA,Psoriatic arthritis,2660,3268,24 months,706,21.603427173
Medicare,TNF,PsO/PsA,Psoriatic arthritis,2660,3268,36 months,755,23.102815177
Medicare,TNF,PsO/PsA,Psoriatic arthritis,2660,3268,AS cohort entry to exposure,619,18.94124847
Medicare,TNF,Uveitis,Uveitis,2660,3268,12 months,408,12.484700122
Medicare,TNF,Uveitis,Uveitis,2660,3268,24 months,511,15.636474908
Medicare,TNF,Uveitis,Uveitis,2660,3268,36 months,585,17.900856793
Medicare,TNF,Uveitis,Uveitis,2660,3268,AS cohort entry to exposure,447,13.678090575
